News from Visiopharm


Webinar - Invasive Tumor Detection

September 18th, 2018

13:00-14:00 CEST, 7:00-8:00 AM EDT, 4:00-5:00 AM PDT
Sign up here

18:00-19:00 CEST, 12:00-1:00 PM EDT, 9:00-10:00 AM PDT
Sign up here

 

New APP: PD-L1, Cell Lines, Cancer

This APP can be used for quality control of PD-L1 strong positive, intermediate positive, weak positive and negative cell line material to ensure that each cell line block complies with the expected PD-L1 expression before the material is used as reference standard for IHC assays. The APP quantifies the PD-L1 expression in each cell line core and relates this expression to a known reference value for each cell line expression level.

For more information visit our APP Center

Sign up to our newsletter
* indicates required
Are you a current customer
 

Visiopharm quantitative digital pathology solutions provide pathologists and scientists with a flexible, powerful suite of software to quantify relevant tissue properties in a fast, objective and reproducible way.

Learn more about us

Visit our APP center

The worlds largest and fastest growing

Visit the complete app center

Publications

Visiopharm software is featured in over 1200 international scientific publications. They are based on collaborations with leading scientists in hospitals, biopharmaceutical companies and research institutions around the world. Select a main category to access the publication list.